St Dennis Thomas sold $140K of ACLS

St Dennis Thomas sold 900 shares of AXCELIS TECHNOLOGIES INC (ACLS) at $155.37 ($0.14M total) on 2026-05-22.

Original reporting
SEC EDGAR · St Dennis Thomas
Published May 26, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACLS
Neutral
medium confidence
Mentioned
$ACLS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACLSNeutralLow
01

Why it matters

Because the disclosure contains no operational or strategic catalyst, it mainly affects short-term sentiment rather than fundamentals.

02

Market read

Traders may briefly reassess sentiment around ACLS due to insider selling, but the lack of a fundamental catalyst suggests limited trading edge.

03

What to watch

No 10b5-1 plan is disclosed, which can increase headline sensitivity; however, the article provides no context on prior sales cadence or total insider exposure.

Relevance 6/10Timing: Immediate (new SEC Form 4 disclosure) but unlikely to drive sustained repricing.

Background

The article is an SEC Form 4 insider transaction disclosure for Axcelis Technologies, filed the same day as the sale.

Company-level read

Ticker impact

$ACLSNeutralMedium confidence
Context

Axcelis Technologies director St Dennis Thomas sold 900 shares in an open-market transaction at $155.37, per SEC Form 4.

Expected impact

Likely limited near-term impact; any reaction should fade unless follow-on filings or fundamentals change.

Evidence & confidence

The filing is a routine insider transaction with no stated reason, no earnings/guidance/M&A/drug catalyst, and only a small share count relative to typical daily liquidity.

Market effects

Minimal; this is company-specific insider activity with no sector-wide read-across provided.

None indicated.

None indicated.

Counterpoint

The sale may reflect diversification or personal liquidity needs rather than negative outlook, especially since holdings remain substantial after the trade.

Key entities

  • Axcelis Technologies Inc

    Subject of the insider transaction disclosure; director sold 900 shares at $155.37.

  • St Dennis Thomas

    Director who executed the open-market sale; holdings after sale were 17,695 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Axcelis Technologies, Inc. Q3 2026 Earnings Call Summary

Axcelis Technologies reported Q3 2026 earnings exceeding expectations, driven by higher revenue and lower expenses, despite FX headwinds. AI demand in data centers and memory sectors boosted performance. CS&I revenue hit a record $93M. The company expects 2027 growth and a Q1 2027 merger close with Veeco. Gross margin was 41.2%, affected by currency fluctuations. A new CFO was appointed, and operating expenses were lower than forecasted.

$ACLSHighAI 8/10

Axcelis (ACLS) Q3 2026 Earnings Call Transcript

Axcelis (ACLS) reported Q3 2026 revenue of $238M and EPS of $1.26, beating expectations. Systems revenue grew, driven by power and memory markets, while CS&I revenue hit a record. Book-to-bill ratio was 1.5. The company expects 2027 growth across memory, power, and general mature markets, supported by customer investments and new technologies.

$ACLSMed

What Axcelis Technologies (ACLS) Said on Its Q3 Earnings Call

Axcelis Technologies (ACLS) reported Q3 earnings, highlighting increased silicon carbide sales and rising power bookings. Memory sales were 20% of system sales, with DRAM revenue expected to surpass $90M in 2026. The company plans a $35M manufacturing facility in Korea. Q4 guidance includes a 42.5% gross margin and $56M adjusted EBITDA. The merger with Veeco Instruments is expected to close by Q1 2027. Jeroen Delsman will join as CFO on November 12.

$ACLSMedAI 8/10

Axcelis Announces Financial Results for Third Quarter 2026

AXCELIS TECHNOLOGIES INC (ACLS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Axcelis Announces Financial Results for Third Quarter 2026 Q3 2026 Highlights: · Revenue of $237.8 million · GAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2% · GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6% · GAAP Dil